PROM1 and glioblastoma: Gene expression studies comparing proneuronal with mesenchymal GBM subtypes showed, nevertheless, that expression of CD133 was enhanced in mesenchymal GBM and in proneuronal GBM that recurred and changed upon recurrence into a more mesenchymal type [34].